Aberdeen Asset Management PLC UK boosted its stake in Clorox Company (The) (NYSE:CLX) by 18.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,457 shares of the company’s stock after acquiring an additional 5,548 shares during the period. Aberdeen Asset Management PLC UK’s holdings in Clorox Company (The) were worth $4,724,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently bought and sold shares of CLX. BlackRock Inc. increased its stake in Clorox Company (The) by 1,402.2% during the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after purchasing an additional 9,698,542 shares during the last quarter. Vanguard Group Inc. increased its stake in Clorox Company (The) by 4.8% during the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after purchasing an additional 649,766 shares during the last quarter. Morgan Stanley increased its stake in Clorox Company (The) by 31.9% during the first quarter. Morgan Stanley now owns 996,369 shares of the company’s stock valued at $134,342,000 after purchasing an additional 241,210 shares during the last quarter. Wells Fargo & Company MN increased its stake in Clorox Company (The) by 5.3% during the second quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after purchasing an additional 221,168 shares during the last quarter. Finally, WINTON GROUP Ltd increased its stake in Clorox Company (The) by 762.4% during the first quarter. WINTON GROUP Ltd now owns 228,197 shares of the company’s stock valued at $28,566,000 after purchasing an additional 201,737 shares during the last quarter. 71.28% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have weighed in on CLX shares. BidaskClub lowered shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price for the company in a research note on Tuesday, July 4th. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 target price (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the company a “buy” rating in a research note on Thursday, August 3rd. Finally, Barclays PLC reiterated an “equal weight” rating and set a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the company. Clorox Company (The) currently has an average rating of “Hold” and an average target price of $129.05.

ILLEGAL ACTIVITY NOTICE: “Clorox Company (The) (CLX) Position Increased by Aberdeen Asset Management PLC UK” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/16/clorox-company-the-clx-position-increased-by-aberdeen-asset-management-plc-uk.html.

In other news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares in the company, valued at $2,862,666.18. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 21,242 shares of company stock valued at $2,944,449. 0.74% of the stock is currently owned by corporate insiders.

Shares of Clorox Company (NYSE:CLX) opened at 136.18 on Friday. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The company has a 50-day moving average of $135.92 and a 200 day moving average of $135.24. The firm has a market cap of $17.58 billion, a P/E ratio of 25.53 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.65 billion. During the same period last year, the company posted $1.30 earnings per share. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. Equities analysts predict that Clorox Company will post $5.66 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Stockholders of record on Wednesday, October 25th will be paid a $0.84 dividend. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.47%. Clorox Company (The)’s dividend payout ratio (DPR) is presently 63.04%.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.